218 MTHFR C677T and other inherited coagulation disorders in budd chiari syndrome (BCS) and portal vein thrombosis (PVT) with or without liver cirrhosis (LC)

2005 ◽  
Vol 42 ◽  
pp. 85
2004 ◽  
Vol 121 (6) ◽  
pp. 844-847 ◽  
Author(s):  
Maitreyee Bhattacharyya ◽  
Govind Makharia ◽  
M. Kannan ◽  
R.P.H. Ahmed ◽  
P.K. Gupta ◽  
...  

2009 ◽  
Vol 13 (1) ◽  
pp. 127-144 ◽  
Author(s):  
Paulo Lisboa Bittencourt ◽  
Cláudia Alves Couto ◽  
Daniel Dias Ribeiro

2004 ◽  
Vol 124 (3) ◽  
pp. 329-335 ◽  
Author(s):  
Alberto Alvarez-Larrán ◽  
Juan Carlos García-Pagán ◽  
Juan G. Abraldes ◽  
Eduardo Arellano ◽  
Juan Carlos Reverter ◽  
...  

2004 ◽  
Vol 78 (1) ◽  
pp. 333-334 ◽  
Author(s):  
George K Anagnostopoulos ◽  
George Margantinis ◽  
Panagiotis Kostopoulos ◽  
Glyceria Papadopoulou ◽  
Athanassios Roulias ◽  
...  

2016 ◽  
Vol 111 ◽  
pp. S815-S816
Author(s):  
Yezaz A. Ghouri ◽  
Akhil V. Shenoy ◽  
Heather L. Stevenson ◽  
Shehzad Merwat

Blood ◽  
2012 ◽  
Vol 120 (25) ◽  
pp. 4921-4928 ◽  
Author(s):  
Jasper H. Smalberg ◽  
Lidia R. Arends ◽  
Dominique C. Valla ◽  
Jean-Jacques Kiladjian ◽  
Harry L. A. Janssen ◽  
...  

Abstract Myeloproliferative neoplasms (MPNs) are the most common cause of Budd-Chiari syndrome (BCS) and nonmalignant, noncirrhotic portal vein thrombosis (PVT). In this meta-analysis, we determined the prevalence of MPNs and their subtypes as well as JAK2V617F and its diagnostic role in these uncommon disorders. MEDLINE and EMBASE databases were searched. Prevalence of MPNs, JAK2V617F, and MPN subtypes were calculated using a random-effects model. A total of 1062 BCS and 855 PVT patients were included. In BCS, mean prevalence of MPNs and JAK2V617F was 40.9% (95% CI, 32.9%-49.5%) and 41.1% (95% CI, 32.3%-50.6%), respectively. In PVT, mean prevalence of MPNs and JAK2V617F was 31.5% (95% CI, 25.1%-38.8%) and 27.7% (95% CI, 20.8%-35.8%), respectively. JAK2V617F and MPNs were more frequent in BCS compared with PVT (P = .03 and P = .09, respectively). Polycythemia vera was more prevalent in BCS than in PVT (P = .001). JAK2V617F screening in splanchnic vein thrombosis (SVT) patients without typical hematologic MPN features identified MPN in 17.1% and 15.4% of screened BCS and PVT patients, respectively. These results demonstrate a high prevalence of MPNs and JAK2V617F in SVT patients and show differences in underlying etiology between these disorders. Furthermore, these results validate routine inclusion of JAK2V617F in the diagnostic workup of SVT patients.


2014 ◽  
Vol 33 (5) ◽  
pp. 489-491 ◽  
Author(s):  
Mohammed Amin Sakr ◽  
Nadia Abdelkader ◽  
Hany Dabbous ◽  
Ahmed Eldorry

Sign in / Sign up

Export Citation Format

Share Document